Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30779531

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Mar 21
First author
Motzer RJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2019 Mar 21;380(12):1176-1178. doi: 10.1056/NEJMe1900887.
    note
    Source null
    related pmid
    30779526
    relationship
    Comment in
  2. citation
    Nat Rev Nephrol. 2019 Jun;15(6):324-325. doi: 10.1038/s41581-019-0149-0.
    note
    Source null
    related pmid
    30992548
    relationship
    Comment in
  3. citation
    N Engl J Med. 2019 Jun 27;380(26):2581. doi: 10.1056/NEJMc1905518.
    note
    Source null
    related pmid
    31242369
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Jun 27;380(26):2582. doi: 10.1056/NEJMc1905518.
    note
    Source null
    related pmid
    31242371
    relationship
    Comment in
  5. citation
    Transl Cancer Res. 2019 Dec;8(8):E1-E6. doi: 10.21037/tcr.2019.07.02.
    note
    Source null
    related pmid
    35117054
    relationship
    Comment in
  6. citation
    Transl Cancer Res. 2019 Dec;8(Suppl 6):S585-S588. doi: 10.21037/tcr.2019.06.39.
    note
    Source null
    related pmid
    35117136
    relationship
    Comment in

Authors and identifiers

  1. name
    Motzer RJ
    type
    Author
  2. name
    Penkov K
    type
    Author
  3. name
    Haanen J
    type
    Author
  4. name
    Rini B
    type
    Author
  5. name
    Albiges L
    type
    Author
  6. name
    Campbell MT
    type
    Author
  7. name
    Venugopal B
    type
    Author
  8. name
    Kollmannsberger C
    type
    Author
  9. name
    Negrier S
    type
    Author
  10. name
    Uemura M
    type
    Author
  11. name
    Lee JL
    type
    Author
  12. name
    Vasiliev A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Motzer RJ
    type
    Author
  2. name
    Penkov K
    type
    Author
  3. name
    Haanen J
    type
    Author
  4. name
    Rini B
    type
    Author
  5. name
    Albiges L
    type
    Author
  6. name
    Campbell MT
    type
    Author
  7. name
    Venugopal B
    type
    Author
  8. name
    Kollmannsberger C
    type
    Author
  9. name
    Negrier S
    type
    Author
  10. name
    Uemura M
    type
    Author
  11. name
    Lee JL
    type
    Author
  12. name
    Vasiliev A
    type
    Author
bibliography ids
  1. nci-bib-8dd21c76e3c9dfaefcfffd6f
book metadata
content sha256
936cb2139cd3a45ccc47c27c1626b4ef73f0c05afe183b8cd8508017d9876782
document type
citation
dois
  1. 10.1056/NEJMoa1816047
electronic publication date
display
2019 Feb 16
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:30779531
immutable id
pubmed:30779531@936cb2139cd3a45ccc47c27c1626b4ef73f0c05afe183b8cd8508017d9876782
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
12
name
The New England journal of medicine
nlm unique id
0255562
pages
1103-1115
volume
380
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2019 Mar 21;380(12):1176-1178. doi: 10.1056/NEJMe1900887.
    note
    Source null
    related pmid
    30779526
    relationship
    Comment in
  2. citation
    Nat Rev Nephrol. 2019 Jun;15(6):324-325. doi: 10.1038/s41581-019-0149-0.
    note
    Source null
    related pmid
    30992548
    relationship
    Comment in
  3. citation
    N Engl J Med. 2019 Jun 27;380(26):2581. doi: 10.1056/NEJMc1905518.
    note
    Source null
    related pmid
    31242369
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Jun 27;380(26):2582. doi: 10.1056/NEJMc1905518.
    note
    Source null
    related pmid
    31242371
    relationship
    Comment in
  5. citation
    Transl Cancer Res. 2019 Dec;8(8):E1-E6. doi: 10.21037/tcr.2019.07.02.
    note
    Source null
    related pmid
    35117054
    relationship
    Comment in
  6. citation
    Transl Cancer Res. 2019 Dec;8(Suppl 6):S585-S588. doi: 10.21037/tcr.2019.06.39.
    note
    Source null
    related pmid
    35117136
    relationship
    Comment in
outcomes validated
false
pmid
30779531
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
f6e9a15426429782ab430d193c0b1ac401bdb3cf5c95e956659a083867433c06
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2019 Mar 21
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, N.I.H., Extramural
  7. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30779531/
title
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Preserved source evidence · Not medical advice